fashion -WSS

fashion

author：explore 2025-09-30 20:47:34 - browse：652

Stacks of silver coins surrounded by a medicare health insurance card — insurance coverage from STAT — Adobe

The federal government is cutting the average benchmark payments for 2025 Medicare Advantage plans by 0.2%, according to proposed rules released by the Biden administration on Wednesday.

The slight proposed cut is mostly the result of the second year of the government’s phased-in changes to the way Medicare Advantage insurers code and report the health conditions of their members — a process known as risk adjustment. However, the government estimates Medicare Advantage plans would still cumulatively receive $16 billion more in 2025 than they got this year, assuming insurers continue their intensive coding practices.

The latest proposals reinforce how the Biden administration, as well as the Trump and Obama administrations, have bolstered Medicare Advantage even though the program costs taxpayers far more than traditional Medicare and has caused considerable concern over inappropriate denials of care. And while Biden has done more to reform Medicare Advantage than prior administrations, this set of proposals — which comes during a presidential election year — is mild.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Key Senate panel to consider PBM, drug pricing reform package

WSS

Live blog: Hearing on CRISPR

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Ending racial health disparities hinges on penalties, political will

DeSantis talks Trump, trans issues and 'what wokeness is'

Tocagen's brain cancer gene therapy trial continues. Investors worry

Humans aren't the only ones with an imagination. Rats have it too

explore

fashion

knowledge

After affirmative action ruling, medical educators look to 'holistic review'

Key Senate panel to consider PBM, drug pricing reform package

Bright Health sells Medicare Advantage business to Molina

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Moonlake's readout produced a cash windfall. Risks remain

After Sarepta trial failure, Duchenne families brace for more debate

At least 13 dead in Texas as scorching temps continue

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

Alkermes shareholders re

Life sciences investors close nearly $6 billion in new funds

explore

Sarepta Duchenne therapy fails to meet primary endpoint in trial

I learned firsthand about improving diversity in clinical trials

Explaining an after

Life sciences investors close nearly $6 billion in new funds

Life sciences investors close nearly $6 billion in new funds

Medicare proceeds with plan to claw back hospital funds

knowledge

hotspot

Wikipedia

knowledge